Drug Profile
Ambroxol/levodropropizine
Alternative Names: Ambroxol HCl/levodropropizine; HCP1103; Levodropropizine/ambroxol; Levodropropizine/ambroxol HClLatest Information Update: 04 May 2015
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Antitussives; Expectorants; Small molecules
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cough
Most Recent Events
- 04 May 2015 No development reported - Phase-I for Cough (In volunteers) in South Korea (PO)
- 31 Dec 2011 Preclinical trials in Cough in South Korea (PO)